The Body
What caffeine actually does to your physical performance, your heart, your gut, your hydration, and your bones, and why it is one of the most effective legal performance aids in existence.
Written for anyone who has felt the difference coffee makes before a training session, and has also wondered about the warnings, whether it dehydrates you, whether it is bad for your heart, whether it costs you something in the long run.
One of the most effective performance aids we have access to
Caffeine is a legitimate ergogenic aid. If you feel like coffee before a workout gives you a real edge, you are not imagining it. The effect is measurable, consistent across hundreds of well-designed studies, and acts through mechanisms that affect both the brain and the muscle itself.
For endurance, strength, power output, and reaction time, moderate caffeine improves performance by an amount that is small in any single session but cumulatively meaningful over weeks and months of training. This is why caffeine is the single most commonly used ergogenic substance in elite sport, and why removing it from the banned substances list in 2004 changed very little, most athletes were already using it.
The edge caffeine gives you before a session is real. Small in any single workout, cumulatively meaningful across a training block.
When to take it matters almost as much as how much
Caffeine takes roughly 45 to 60 minutes to reach peak plasma concentration after a capsule or tablet, and about 30 to 45 minutes after coffee. For most training sessions, a cup 45 minutes before you start is the sweet spot. Much earlier and you have started to clear it before the hardest work begins. Much later and you are still climbing the absorption curve during your warm-up.
There is a trade-off most people underestimate. Caffeine has a half-life of roughly five hours, which means a 2pm training session fuelled by coffee can still be compromising your sleep at midnight. The closer your workout is to your bedtime, the more carefully you have to think about dose and timing, or whether you want the caffeine at all.
For morning sessions: a normal cup (roughly 80 to 120mg) 45 minutes before you start is enough for most recreational training. For longer or harder sessions, a second cup, or a single stronger one, takes you toward the 3 to 6mg/kg range.
For evening sessions: be honest about whether the performance benefit is worth the sleep cost. For most people training after 5pm, it is not. Consider a smaller dose, or none at all.
If you already drink coffee daily: your tolerance reduces but does not eliminate the ergogenic effect. Most studies still show meaningful benefit in habitual users.
Forty-five minutes before a session hits the sweet spot. Earlier and you have started to clear it. Later and you are still climbing.
Coffee does not dehydrate you the way everyone says it does
For decades people have been told that coffee is a diuretic, that it works against hydration, and that anyone exercising should avoid caffeine or compensate with extra water. The modern evidence does not support this, at least not for habitual coffee drinkers.
Tolerance to the diuretic effect develops within about four days of regular intake. In people who drink coffee daily, the fluid balance effect of a cup of coffee is not meaningfully different from the same volume of water. Coffee counts toward your daily fluid intake. It does not subtract from it.
The practical upshot: if you drink coffee most days, you do not need to drink extra water to compensate for it, and you do not need to avoid it before exercise on hydration grounds. Other reasons to moderate intake still apply, but dehydration is not one of them for habitual users.
The warning to avoid caffeine around training for hydration reasons is outdated. It reflects early studies in caffeine-naive subjects, not habitual users.
What happens to your cardiovascular system when you drink coffee
Caffeine produces a small, transient rise in blood pressure, typically 3 to 8 mmHg, lasting two to three hours after a moderate dose. Heart rate may rise slightly, or occasionally fall slightly in regular users as the body adapts. For the vast majority of healthy adults, these effects are clinically irrelevant and do not translate into any meaningful long-term cardiovascular risk.
The picture is different for specific groups. People with uncontrolled hypertension, known arrhythmias, ischaemic heart disease, or those on certain cardiac medications may need to moderate or eliminate caffeine depending on the specifics. If you have a cardiac diagnosis, this is a conversation to have with your cardiologist rather than a decision to make from a webpage.
For everyone else, the long-term data is reassuring. Moderate coffee consumption is, if anything, mildly associated with better cardiovascular outcomes at the population level. It is not hurting your heart.
Why coffee sends you to the bathroom
Coffee stimulates colonic motility, the muscular contractions that move contents along the large intestine, within about four minutes of drinking it. This is why coffee often produces a predictable urge to use the bathroom, particularly the first coffee of the morning. The effect is driven partly by caffeine and partly by other compounds in coffee, which is why decaffeinated coffee has a similar effect for some people.
For most people, this is benign and arguably useful. For people with irritable bowel syndrome, reflux, or acid-sensitive stomach symptoms, coffee is more complicated and often worth trialling removal for a period to see whether symptoms improve.
The combination of a meaningful ergogenic effect, low cost, easy access, and a long safety record makes coffee one of the most favourable performance-to-risk ratios of any legal substance available. For healthy adults training recreationally, there is very little reason to avoid it and plenty of reason to use it thoughtfully.
Covers ergogenic mechanisms and optimal dose-timing protocols, cardiovascular effects and arrhythmogenesis, gastrointestinal effects, hydration and fluid balance evidence, bone metabolism and calcium interactions, iron absorption inhibition, and the testosterone-to-cortisol ratio relevant to training adaptation.
How caffeine improves physical performance
Caffeine's ergogenic effect is mediated through at least five convergent mechanisms: adenosine A1 and A2A receptor antagonism reducing perceived effort and extending time to fatigue; enhanced sympathoadrenal activation increasing lipolysis and glycogen sparing; direct effects on skeletal muscle including altered calcium handling at the sarcoplasmic reticulum and enhanced Na+/K+ ATPase activity; CNS effects increasing motor unit recruitment; and reduced pain perception through central and peripheral adenosine receptor blockade affecting nociceptive signalling.
Meta-analytic evidence (Grgic et al., 2018, 2020) supports a consistent performance-enhancing effect of approximately 2 to 7 per cent across exercise modalities, including endurance (SMD 0.41), muscular strength (SMD 0.20), muscular endurance (SMD 0.38), and anaerobic power (SMD 0.24). The ergogenic benefit is maintained in habitual users, although modestly attenuated relative to caffeine-naive subjects.
Dose-response studies (Goldstein et al., 2010; Graham, 2001) establish 3 to 6mg/kg as the optimal range for most exercise types. Doses above 9mg/kg do not produce additional benefit and carry increased risk of tachycardia, anxiety, and gastrointestinal symptoms that can impair performance.
Peak plasma concentration occurs at 45 to 60 minutes post-ingestion for anhydrous caffeine and 30 to 45 minutes for coffee, with interindividual variation of approximately 30 per cent. For events lasting under 90 minutes, single pre-exercise dosing is sufficient. For longer events, split dosing with a smaller bolus mid-event extends the ergogenic window without exceeding tolerance thresholds.
Caffeinated gums and mouth rinses bypass gastric absorption and produce faster onset (5 to 15 minutes), making them useful for late-event dosing in endurance sport. Mouth rinsing alone produces measurable performance benefit in short-duration sprint protocols through oral receptor activation independent of plasma caffeine.
Acute responses and long-term risk
Acute caffeine consumption produces a transient increase in systolic blood pressure of 3 to 8 mmHg lasting two to three hours post-dose in caffeine-naive individuals, with substantial tolerance developing within one to two weeks of regular use. Heart rate responses are mixed: small increases in caffeine-naive subjects, minimal change or slight reduction in habitual users due to enhanced vagal tone.
The arrhythmogenic potential of caffeine has been extensively studied. Caldeira et al. (2013, meta-analysis of 11 studies) and subsequent analyses found no significant association between moderate caffeine intake and atrial fibrillation or ventricular arrhythmia in healthy populations. For patients with established arrhythmia, individual sensitivity varies and symptom-guided moderation is appropriate.
Long-term epidemiological data (Poole et al., 2017, umbrella review) support a J-shaped dose-response relationship between coffee intake and cardiovascular mortality, with maximum risk reduction at approximately three to four cups daily. The protective association is attributed to combined effects of polyphenols, antioxidants, and modest metabolic benefits rather than caffeine itself.
The most clinically underappreciated caffeine interaction is not cardiovascular or neurological, it is nutritional, through iron and calcium absorption.
The most clinically underappreciated caffeine interaction
Coffee substantially inhibits non-haem iron absorption through chlorogenic acids and polyphenolic compounds that form insoluble complexes with iron in the gut. Morck et al. (1983) and Hallberg and Rossander (1982) demonstrated that a cup of coffee consumed with or within one hour after a meal reduces non-haem iron absorption by 39 to 90 per cent, depending on coffee strength and meal composition.
This is clinically significant in iron deficiency and iron deficiency anaemia, and particularly in menstruating women, pregnant patients, vegetarians, vegans, and patients with malabsorption syndromes. The standard recommendation in any patient with suboptimal iron status is to separate coffee consumption from iron-rich meals and from oral iron supplementation by at least one hour, preferably two.
Tea is a stronger inhibitor than coffee through a similar mechanism (tannins). Calcium and phytates also inhibit non-haem iron absorption, creating a compounded effect when tea or coffee is consumed with a plant-based iron source.
For any patient on oral iron supplementation or being treated for iron deficiency, the single most useful behavioural adjustment is to consume coffee and tea at least one hour before or two hours after iron-containing meals and iron supplements. This intervention is frequently more impactful than the specific iron formulation or dose chosen, particularly in patients who have not previously been advised on timing.
Caffeine, calcium, and bone density
High caffeine intake produces a small increase in urinary calcium excretion and a transient reduction in intestinal calcium absorption (Heaney, 2002). The effect is modest, approximately 4 to 6mg of calcium loss per 100mg of caffeine, and is readily offset by adequate calcium intake.
Long-term observational studies (Hallström et al., 2013; Barrett-Connor et al., 1994) show either no association or a small negative association between high coffee intake and bone mineral density, with effects generally limited to patients with low habitual calcium intake. The practical implication is that caffeine intake is not a primary concern for bone health in patients meeting calcium recommendations, but may represent an additional risk modifier in postmenopausal women, patients with osteoporosis, or those with inadequate dietary calcium.
Motility, reflux, and irritable bowel interaction
Coffee stimulates colonic motor activity within four minutes of ingestion (Rao et al., 1998) through mechanisms that are partly caffeine-mediated and partly attributable to other compounds in coffee, as evidenced by similar motility responses to decaffeinated preparations. The gastrocolic response to coffee is stronger than that to a standard meal, explaining the common post-coffee urge to defecate.
Coffee reduces lower oesophageal sphincter pressure and increases gastric acid secretion, contributing to reflux symptoms in susceptible patients. Pepin-Donat et al. and subsequent studies have identified coffee as a significant trigger in approximately 40 per cent of patients with GORD. Elimination trials are reasonable first-line in symptomatic patients, with return to intake guided by symptom response.
For IBS, the evidence is mixed and individual. Caffeine-mediated motility enhancement can worsen diarrhoea-predominant IBS and improve constipation-predominant IBS. Personalised elimination and reintroduction is more useful than blanket recommendation.
Maughan and Griffin (2003) and Killer et al. (2014) established that the diuretic effect of caffeine is substantially attenuated by tolerance developing over approximately four days of regular intake. In habitual users consuming up to 400mg daily, coffee consumption does not produce clinically meaningful negative fluid balance and coffee volumes count toward daily fluid intake at approximately 80 to 90 per cent of equivalent water.
The clinical advice to avoid caffeine in the hours before exercise for hydration reasons reflects early studies performed in caffeine-naive subjects and does not generalise to habitual users. This is one of the most persistent outdated pieces of sports nutrition advice still in circulation.
Caffeine and the anabolic-catabolic environment
Beaven et al. (2008) demonstrated that 4mg/kg caffeine administered pre-exercise increased salivary testosterone by approximately 15 per cent and reduced cortisol, producing a net improvement in the testosterone-to-cortisol ratio, a recognised marker of anabolic readiness. The effect is acute and does not translate into sustained endocrine change, but is relevant to acute session quality and recovery capacity.
The relevance is particularly clear in high-intensity training contexts where the quality of individual sessions determines adaptation. Caffeine's acute effect on the neuroendocrine environment is one mechanism through which its performance benefit extends beyond the single session into training adaptation over weeks.
Key takeaways from The Body
Caffeine is one of the most consistently supported ergogenic substances in existence, with meta-analytic evidence for a 2 to 7 per cent performance benefit at 3 to 6mg/kg dosing, taken 45 to 60 minutes pre-exercise. The benefit is maintained in habitual users.
The hydration warning is outdated. Tolerance to the diuretic effect develops within four days in regular users, and coffee counts toward daily fluid intake at approximately 80 to 90 per cent of equivalent water.
Coffee substantially inhibits non-haem iron absorption through chlorogenic acids and polyphenols, reducing uptake by 39 to 90 per cent when consumed with or immediately after iron-containing meals. Separation by one to two hours is the single most impactful intervention in iron deficiency management.
Cardiovascular effects are modest and transient in healthy adults, with long-term data showing a J-shaped protective association at three to four cups daily. Caution applies in established arrhythmia, uncontrolled hypertension, and ischaemic heart disease.
Caffeine acutely improves the testosterone-to-cortisol ratio (Beaven et al., 2008), contributing to session quality and training adaptation beyond the within-session ergogenic effect.
